ArticleStem cell reports2021

A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients.

Jia Xin Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.